Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth's Novel AI-Powered Breast Cancer Detection Workflow

Impact · against what's priced in

The publication of the ASSURE study in Nature Health provides significant clinical validation for RadNet's AI-powered breast cancer detection workflow, demonstrating a 21.6% increase in detection rates. This real-world evidence from 579,000 patients creates a strong catalyst for broader adoption of the EBCD™ program and improves the company's competitive positioning in diagnostic imaging.

RDNT+0.70

No priced-in read yet